Marisol Ruiz Meana I have a degree in Veterinary Medicine and a Master's degree in Biochemistry from the Autonomous University of Barcelona. I obtained my PhD at the VHIR Cardiovascular Diseases’ group under the supervisión of Prof. David Garcia-Dorado on the mechanisms of cell death during myocardial ischemia-reperfusion. I am currently Principal Investigator of the group and since 2019 I have assumed the coordination of the laboratory. I’m a professor of the Master's Degree in Translational Biomedical Research at VHIR and have supervised 5 doctoral theses in the last years. I have an H index of 42. Institutions of which they are part Main researcher Cardiovascular Diseases Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Marisol Ruiz Meana LinkedIn Twitter Orcid Email Institutions of which they are part Main researcher Cardiovascular Diseases Vall Hebron Institut de Recerca I have a degree in Veterinary Medicine and a Master's degree in Biochemistry from the Autonomous University of Barcelona. I obtained my PhD at the VHIR Cardiovascular Diseases’ group under the supervisión of Prof. David Garcia-Dorado on the mechanisms of cell death during myocardial ischemia-reperfusion. I am currently Principal Investigator of the group and since 2019 I have assumed the coordination of the laboratory. I’m a professor of the Master's Degree in Translational Biomedical Research at VHIR and have supervised 5 doctoral theses in the last years. I have an H index of 42.
I have been dedicated to cardiovascular research since 1993, when I began my doctoral thesis under the direction of Dr. Garcia-Dorado, in the laboratory of Cardiovascular Diseases of the Vall d'Hebron Hospital. I completed my training with an international stay in the physiology laboratory of Prof. Hans Michael Piper, at the University of Dusseldorf, which allowed me to learn the model of isolated adult cardiomyocytes (we were pioneers in our country), one of the fundamental pillars of our research, and become familiar with (ratio)fluorescence imaging techniques for real-time quantification of intracellular ionic changes in cardiomyocytes. Since then, I have specialized in studies of cell biology and mitochondrial pathophysiology within the field of cardioprotection, mainly in the context of myocardial infarction. In recent years I have focused my interest on research into the mechanisms of aging and its impact on cardiomyocyte dysfunction, alterations in the interorganelle communication between the sarcoplasmic reticulum and mitochondria, and the accumulation of advanced glycation products as triggers of cell senescence. Our research group, integrated within the Cardiology Service directed by Dr. Ignacio Ferreira, has been recognized as a Consolidated Research Group by the Generalitat of Catalonia and belongs to the Spanish network CIBER-CV. I am currently Principal Investigator of two projects on cardiovascular aging financed by the Instituto de Salud Carlos III and the Spanish Society of Cardiology, and I’m the vice-chair of a COST action financed by the European Union that brings together researchers from more than 35 countries with a common scientific interest in heart failure (EU-COST METAHEART). My teaching activity includes the training of postgraduate students as a professor and coordinator of the Cardiovascular Diseases module of the Master in Translational Biomedical Research at the VHIR, and the training of doctoral students. I have been a member of the Internal Scientific Committee of my institution since 2018.
Projects Daño mitocondrial por estrés dicarbonílico como impulsor de la senescencia: papel de los senolíticos en la protección del corazón durante el envejecimiento. IP: Marisol Ruiz Meana Collaborators: Rafael Rodríguez Lecoq, David Aluja Gonzalez, Elisabet Miro Casas Funding agency: Instituto de Salud Carlos III Funding: 159720 Reference: PI22/00513 Duration: 01/01/2023 - 31/12/2025 Personal Investigador para Grupo Cardiovascular IP: Ignacio Ferreira González Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00758 Duration: 01/01/2022 - 30/06/2025 Alteraciones de la ATP sintasa mitocondrial inducidas por el envejecimiento: papel en la muerte de los cardiomiocitos durante el daño por isquemia-reperfusión IP: Marisol Ruiz Meana Collaborators: - Funding agency: -Sociedad Española de Cardiologia Funding: 15000 Reference: SEC/INV.BASICA/2021/RUIZ Duration: 22/06/2021 - 21/06/2022 Papel diferencial de los canales TRPV4 en el desarrollo del remodelado cardiaco patológico frente al fisiológico: actuando sobre nuevas vías para el tratamiento de la insuficiencia cardiaca IP: Begoña Benito Villabriga Collaborators: Ignacio Ferreira González, Antonio Rodríguez Sinovas, Laia Yañez Bisbe, Marisol Ruiz Meana, Javier Inserte Igual Funding agency: -Sociedad Española de Cardiologia Funding: 15000 Reference: SEC/FEC-INV-BAS 20/016), Duration: 01/01/2021 - 31/12/2021 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Page 5 … Next page › Last page »
